Drug Profile
Alogliptin/pioglitazone - Takeda
Alternative Names: Alogliptin/Actos; Incresync; Liovel HD; Liovel LD; NESINA PIO; Nesina Pio; NesinaAct; Oseni; Pioglitazone/alogliptin; SYR 322/pioglitazone; SYR-322-4833 BLLatest Information Update: 09 Mar 2022
Price :
$50
*
At a glance
- Originator Takeda
- Class Antihyperglycaemics; Benzonitrile; Piperidines; Pyrimidinones; Small molecules; Thiazolidinediones
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Type 2 diabetes mellitus